Search results
CD7 expression tied to poorer outcomes with newly diagnosed leukemia
Medical Xpress· 6 hours agoCD7 expression is associated with poorer outcomes in patients with newly diagnosed acute myeloid ...
...for Treatment of Adenoid Cystic Carcinoma (ACC) and Acute Myeloid Leukemia/Myelodysplastic...
CBS 47 Fresno· 3 days agoAdditionally, the company also announced that REM-422 has received Orphan Drug Designation from the FDA for the treatment of ACC and AML...
Testing for residual cancer cells before blood cell transplant therapy is important and practical,...
Medical Xpress· 2 days ago"The good news is this testing is doable," said Christopher Hourigan, a Virginia Tech professor of...
MorphoSys Says Novartis Deal Progressing Steadily Despite Safety Concerns Over Bone Marrow Cancer...
Benzinga· 5 days agoMorphoSys AG MOR is reportedly facing a burgeoning safety concern surrounding pelabresib, an...
Moleculin Announces Formation of Scientific Advisory Board to Support Development of Annamycin
KTLA-TV Los Angeles· 3 days agoMartin Tallman. Dr. Tallman is an internationally renowned clinical investigator whose discoveries have fueled the progress of leukemia-targeting therapies, most recently ...
More bones found in Mass. creek where skull was discovered
The Republican· 2 days agoAdditional human bones were found in Easton on Thursday as officials continued to search the area...
Grandmother, granddaughter fight cancer together
The Port Lavaca Wave· 2 days agoWhen faced with cancer at the same time, a grandmother and her grandchild are strengthening their bond as they fight together. Calhoun High School...
I-95 in Connecticut will close for days after fiery crash damages bridge, governor says
The Republican· 2 days agoThe major traffic artery linking New England with New York will be closed in Connecticut for days...
Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024
Morningstar· 4 days agoCuris, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company ...
Myelofibrosis: A Rare Malignancy Attracting More and More Attention
MedPage Today· 4 days agoMyelofibrosis remains a rare disease, even though recent attention to the condition might suggest...